(Q48525205)

English

Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome.

scientific article published on 23 May 2006

Statements

Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit